{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:28:33Z","timestamp":1788560913720,"version":"build-2803163510"},"reference-count":102,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2018.00292","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:21:06Z","timestamp":1525252866000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":149,"title":["Neuroinflammation as a Target for Intervention in Subarachnoid Hemorrhage"],"prefix":"10.3389","volume":"9","author":[{"given":"Airton Leonardo","family":"de Oliveira Manoel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Loch","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13054-016-1193-9","article-title":"The critical care management of poor-grade subarachnoid haemorrhage","volume":"20","author":"de Oliveira Manoel","year":"2016","journal-title":"Crit Care"},{"key":"B2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0140-6736(16)30668-7","article-title":"Spontaneous subarachnoid haemorrhage","volume":"389","author":"Macdonald","year":"2017","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2013.246","article-title":"Delayed neurological deterioration after subarachnoid haemorrhage","volume":"10","author":"Macdonald","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12028-016-0305-3","article-title":"Functional outcome after poor-grade subarachnoid hemorrhage: a single-center study and systematic literature review","volume":"25","author":"de Oliveira Manoel","year":"2016","journal-title":"Neurocrit Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s00415-014-7365-0","article-title":"Time intervals from subarachnoid hemorrhage to rebleed","volume":"261","author":"Germans","year":"2014","journal-title":"J Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1161\/STROKEAHA.115.010037","article-title":"Predictive factors for rebleeding after aneurysmal subarachnoid hemorrhage: rebleeding aneurysmal subarachnoid hemorrhage study","volume":"46","author":"van Donkelaar","year":"2015","journal-title":"Stroke"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","article-title":"Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group","volume":"41","author":"Vergouwen","year":"2010","journal-title":"Stroke"},{"key":"B8","doi-asserted-by":"publisher","first-page":"j5745","DOI":"10.1136\/bmj.j5745","article-title":"Development and validation of outcome prediction models for aneurysmal subarachnoid haemorrhage: the SAHIT multinational cohort study","volume":"360","author":"Jaja","year":"2018","journal-title":"BMJ"},{"key":"B9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3171\/jns.1978.48.2.0173","article-title":"Time course of vasospasm in man","volume":"48","author":"Weir","year":"1978","journal-title":"J Neurosurg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1161\/STROKEAHA.110.597005","article-title":"Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage","volume":"42","author":"Crowley","year":"2011","journal-title":"Stroke"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1161\/01.STR.32.7.1552","article-title":"Effect of collateral blood flow and cerebral vasomotor reactivity on the outcome of carotid artery occlusion","volume":"32","author":"Vernieri","year":"2001","journal-title":"Stroke"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1161\/01.STR.0000086465.41263.06","article-title":"Collateral circulation","volume":"34","author":"Liebeskind","year":"2003","journal-title":"Stroke"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1001\/jama.283.16.2122","article-title":"Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis","volume":"283","author":"Silvestrini","year":"2000","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1161\/01.STR.0000163090.59350.5a","article-title":"Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage","volume":"36","author":"Rabinstein","year":"2005","journal-title":"Stroke"},{"key":"B15","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/STROKEAHA.110.597914","article-title":"Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects","volume":"42","author":"Vergouwen","year":"2011","journal-title":"Stroke"},{"key":"B16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3171\/jns.1988.68.4.0505","article-title":"Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial","volume":"68","author":"Petruk","year":"1988","journal-title":"J Neurosurg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"CD000277","DOI":"10.1002\/14651858.CD000277.pub3","article-title":"Calcium antagonists for aneurysmal subarachnoid haemorrhage","author":"Dorhout Mees","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/jcbfm.2011.7","article-title":"Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis","volume":"31","author":"Etminan","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3171\/2013.3.JNS121436","article-title":"Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials","volume":"119","author":"Shen","year":"2013","journal-title":"J Neurosurg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/bja\/aes264","article-title":"Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm","volume":"109","author":"Rowland","year":"2012","journal-title":"Br J Anaesth"},{"key":"B21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/00006123-199702000-00010","article-title":"The safety and efficacy of cyclosporine A in the prevention of vasospasm in patients with Fisher grade 3 subarachnoid hemorrhages: a pilot study","volume":"40","author":"Manno","year":"1997","journal-title":"Neurosurgery"},{"key":"B22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF01402450","article-title":"Cyclosporine A prevents neurological deterioration of patients with SAH \u2013 a preliminary report","volume":"112","author":"Ryba","year":"1991","journal-title":"Acta Neurochir"},{"key":"B23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00006123-198708000-00004","article-title":"Preliminary report: effects of high dose methylprednisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage","volume":"21","author":"Chyatte","year":"1987","journal-title":"Neurosurgery"},{"key":"B24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3171\/2009.4.JNS081377","article-title":"Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage","volume":"112","author":"Gomis","year":"2010","journal-title":"J Neurosurg"},{"key":"B25","first-page":"373","article-title":"[Intravenous hydrocortisone in large doses in the treatment of delayed ischemic neurological deficits following subarachnoid hemorrhage \u2013 results of a multi-center controlled double-blind clinical study]","volume":"40","author":"Hashi","year":"1988","journal-title":"No To Shinkei"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e655","DOI":"10.1016\/j.wneu.2017.10.051","article-title":"A propensity score analysis of the impact of dexamethasone use on delayed cerebral ischemia and poor functional outcomes after subarachnoid hemorrhage","volume":"109","author":"Mohney","year":"2018","journal-title":"World Neurosurg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.ajem.2017.09.001","article-title":"Effect of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis","volume":"35","author":"Liu","year":"2017","journal-title":"Am J Emerg Med"},{"key":"B28","first-page":"CD006184","article-title":"Antiplatelet therapy for aneurysmal subarachnoid haemorrhage","author":"Dorhout Mees","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"B29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s12028-016-0266-6","article-title":"Propensity score-matched study of the use of non-steroidal anti-inflammatory agents following aneurysmal subarachnoid hemorrhage","volume":"25","author":"Nassiri","year":"2016","journal-title":"Neurocrit Care"},{"key":"B30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3171\/2012.9.JNS12492","article-title":"Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial","volume":"118","author":"Senbokuya","year":"2013","journal-title":"J Neurosurg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-11-1","article-title":"The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial","volume":"11","author":"Singh","year":"2014","journal-title":"J Neuroinflammation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2017.5.JNS17831","article-title":"Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia","author":"Nagahama","year":"2017","journal-title":"J Neurosurg"},{"key":"B33","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1161\/STROKEAHA.111.633958","article-title":"The albumin in subarachnoid hemorrhage (ALISAH) multicenter pilot clinical trial safety and neurologic outcomes","volume":"43","author":"Suarez","year":"2012","journal-title":"Stroke"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1097\/00006123-200112000-00010","article-title":"Asymptomatic versus symptomatic infarcts from vasospasm in patients with subarachnoid hemorrhage: serial magnetic resonance imaging","volume":"49","author":"Shimoda","year":"2001","journal-title":"Neurosurgery"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1177\/0271678X16641424","article-title":"Oxygen availability and spreading depolarizations provide complementary prognostic information in neuromonitoring of aneurysmal subarachnoid hemorrhage patients","volume":"37","author":"Winkler","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"B36","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1227\/01.NEU.0000227519.27569.45","article-title":"Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study","volume":"59","author":"Stein","year":"2006","journal-title":"Neurosurgery"},{"key":"B37","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/nrneurol.2013.11","article-title":"Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage","volume":"9","author":"Budohoski","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/jcbfm.2013.173","article-title":"The role of the microcirculation in delayed cerebral ischemia and chronic degenerative changes after subarachnoid hemorrhage","volume":"33","author":"Ostergaard","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1161\/01.STR.30.11.2268","article-title":"Initial loss of consciousness and risk of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"30","author":"Hop","year":"1999","journal-title":"Stroke"},{"key":"B40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1001\/jamaneurol.2015.3188","article-title":"Loss of consciousness at onset of subarachnoid hemorrhage as an important marker of early brain injury","volume":"73","author":"Suwatcharangkoon","year":"2016","journal-title":"JAMA Neurol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12028-012-9792-z","article-title":"Clinical prediction models for aneurysmal subarachnoid hemorrhage: a systematic review","volume":"18","author":"Jaja","year":"2012","journal-title":"Neurocrit Care"},{"key":"B42","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/ijms17040497","article-title":"Aneurysmal subarachnoid hemorrhage and neuroinflammation: a comprehensive review","volume":"17","author":"Lucke-Wold","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1227\/01.NEU.0000218821.34014.1B","article-title":"Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale","volume":"59","author":"Frontera","year":"2006","journal-title":"Neurosurgery"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00006123-198001000-00001","article-title":"Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning","volume":"6","author":"Fisher","year":"1980","journal-title":"Neurosurgery"},{"key":"B45","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3171\/jns.2004.101.2.0255","article-title":"Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage","volume":"101","author":"Reilly","year":"2004","journal-title":"J Neurosurg"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1161\/STROKEAHA.115.008728","article-title":"The VASOGRADE: a simple grading scale for prediction of delayed cerebral ischemia after subarachnoid hemorrhage","volume":"46","author":"de Oliveira Manoel","year":"2015","journal-title":"Stroke"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1161\/STROKEAHA.107.484360","article-title":"Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage","volume":"38","author":"Rosengart","year":"2007","journal-title":"Stroke"},{"key":"B48","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1227\/01.NEU.0000068863.37133.9E","article-title":"Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation","volume":"53","author":"Dumont","year":"2003","journal-title":"Neurosurgery"},{"key":"B49","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1179\/016164106X152025","article-title":"Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage","volume":"28","author":"Gallia","year":"2006","journal-title":"Neurol Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.nec.2009.10.008","article-title":"Inflammation and cerebral vasospasm after subarachnoid hemorrhage","volume":"21","author":"Pradilla","year":"2010","journal-title":"Neurosurg Clin N Am"},{"key":"B51","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1471-4159.2012.07716.x","article-title":"The intrathecal CD163-haptoglobin-hemoglobin scavenging system in subarachnoid hemorrhage","volume":"121","author":"Galea","year":"2012","journal-title":"J Neurochem"},{"key":"B52","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fneur.2017.00351","article-title":"Monitoring the neuroinflammatory response following acute brain injury","volume":"8","author":"Thelin","year":"2017","journal-title":"Front Neurol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3389\/fneur.2017.00379","article-title":"Cerebrospinal fluid and microdialysis cytokines in aneurysmal subarachnoid hemorrhage: a scoping systematic review","volume":"8","author":"Zeiler","year":"2017","journal-title":"Front Neurol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3109\/1354750X.2014.881418","article-title":"Biomarkers as outcome predictors in subarachnoid hemorrhage \u2013 a systematic review","volume":"19","author":"Hong","year":"2014","journal-title":"Biomarkers"},{"key":"B55","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.04.004","article-title":"Proteomic biomarker discovery in cerebrospinal fluid for cerebral vasospasm following subarachnoid hemorrhage","volume":"21","author":"Lad","year":"2012","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3171\/jns.1997.87.2.0215","article-title":"Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage","volume":"87","author":"Mathiesen","year":"1997","journal-title":"J Neurosurg"},{"key":"B57","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/jnnp.70.4.534","article-title":"Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries","volume":"70","author":"Fassbender","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B58","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s007010050197","article-title":"Interleukin-6 and development of vasospasm after subarachnoid haemorrhage","volume":"140","author":"Osuka","year":"1998","journal-title":"Acta Neurochir"},{"key":"B59","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s12028-009-9276-y","article-title":"High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage","volume":"11","author":"Nakahara","year":"2009","journal-title":"Neurocrit Care"},{"key":"B60","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1227\/NEU.0b013e31828048ce","article-title":"Correlation among systemic inflammatory parameter, occurrence of delayed neurological deficits, and outcome after aneurysmal subarachnoid hemorrhage","volume":"72","author":"Muroi","year":"2013","journal-title":"Neurosurgery"},{"key":"B61","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12028-010-9432-4","article-title":"Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhage","volume":"13","author":"Sarrafzadeh","year":"2010","journal-title":"Neurocrit Care"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1227\/01.NEU.0000245598.84698.26","article-title":"Complement activation associates with saccularcerebral artery aneurysm wall degeneration and rupture","volume":"59","author":"Tulamo","year":"2006","journal-title":"Neurosurgery"},{"key":"B63","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3171\/jns.1997.87.2.0294","article-title":"The complement membrane attack complex and the bystander effect in cerebral vasospasm","volume":"87","author":"Park","year":"1997","journal-title":"J Neurosurg"},{"key":"B64","first-page":"189","article-title":"Serum complements as indicator for predicting vasospasm and its severity after aneurysmal subarachnoid hemorrhage","volume":"59","author":"Kawano","year":"1990","journal-title":"Nihon Geka Hokan"},{"key":"B65","doi-asserted-by":"publisher","first-page":"560305","DOI":"10.1155\/2013\/560305","article-title":"CSF and serum biomarkers focusing on cerebral vasospasm and ischemia after subarachnoid hemorrhage","volume":"2013","author":"Jung","year":"2013","journal-title":"Stroke Res Treat"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1161\/hs0901.095646","article-title":"Acute systemic inflammatory response syndrome in subarachnoid hemorrhage","volume":"32","author":"Yoshimoto","year":"2001","journal-title":"Stroke"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"B68","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s12028-008-9054-2","article-title":"The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage","volume":"8","author":"Dhar","year":"2008","journal-title":"Neurocrit Care"},{"key":"B69","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12028-010-9402-x","article-title":"Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database","volume":"13","author":"Tam","year":"2010","journal-title":"Neurocrit Care"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/41.suppl_1.1","article-title":"The systemic inflammatory response syndrome: definitions and aetiology","volume":"41","author":"Nystr\u00f6m","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1182\/blood-2002-06-1887","article-title":"The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome","volume":"101","author":"Aird","year":"2003","journal-title":"Blood"},{"key":"B72","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/02688690120082378","article-title":"Systemic inflammatory response syndrome and acute neurological disease","volume":"15","author":"Malham","year":"2001","journal-title":"Br J Neurosurg"},{"key":"B73","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3949\/ccjm.75.Suppl_2.S26","article-title":"Inflammation as a link between brain injury and heart damage: the model of subarachnoid hemorrhage","volume":"75","author":"Mashaly","year":"2008","journal-title":"Cleve Clin J Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1161\/01.STR.31.4.901","article-title":"Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage","volume":"31","author":"Naredi","year":"2000","journal-title":"Stroke"},{"key":"B75","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/SHK.0000000000000642","article-title":"Sympathoadrenal activation is associated with acute traumatic coagulopathy and endotheliopathy in isolated brain injury","volume":"46","author":"Di Battista","year":"2016","journal-title":"Shock"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-017-1620-6","article-title":"Catecholamines as outcome markers in isolated traumatic brain injury: the COMA-TBI study","volume":"21","author":"Rizoli","year":"2017","journal-title":"Crit Care"},{"key":"B77","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12028-011-9588-6","article-title":"Fever management in SAH","volume":"15","author":"Scaravilli","year":"2011","journal-title":"Neurocrit Care"},{"key":"B78","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/neurintsurg-2012-010386","article-title":"Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage","volume":"5","author":"McMahon","year":"2013","journal-title":"J Neurointerv Surg"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3171\/jns.2003.98.6.1222","article-title":"Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage","volume":"98","author":"McGirt","year":"2003","journal-title":"J Neurosurg"},{"key":"B80","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12028-011-9601-0","article-title":"Spontaneous subarachnoid hemorrhage and glucose management","volume":"15","author":"Schmutzhard","year":"2011","journal-title":"Neurocrit Care"},{"key":"B81","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1212\/WNL.0000000000001259","article-title":"Inflammation, negative nitrogen balance, and outcome after aneurysmal subarachnoid hemorrhage","volume":"84","author":"Badjatia","year":"2015","journal-title":"Neurology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12028-016-0292-4","article-title":"The role of platelet activation and inflammation in early brain injury following subarachnoid hemorrhage","volume":"26","author":"Frontera","year":"2016","journal-title":"Neurocrit Care"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/jcbfm.2008.74","article-title":"Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia","volume":"28","author":"Vergouwen","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"B84","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/jcbfm.2015.13","article-title":"Hemostasis and fibrinolysis in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review","volume":"35","author":"Boluijt","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"B85","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1227\/01.NEU.0000108641.98845.88","article-title":"Association between intravascular microthrombosis and cerebral ischemia in traumatic brain injury","volume":"54","author":"Stein","year":"2004","journal-title":"Neurosurgery"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1097\/00006123-200205000-00016","article-title":"Detection of microemboli by transcranial Doppler ultrasonography in aneurysmal subarachnoid hemorrhage","volume":"50","author":"Romano","year":"2002","journal-title":"Neurosurgery"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/sj.jcbfm.9600431","article-title":"Dihydropyridine calcium antagonists increase fibrinolytic activity: a systematic review","volume":"27","author":"Vergouwen","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"B88","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2174\/157488612803251342","article-title":"Non-steroidal anti-inflammatory drugs used as a treatment modality in subarachnoid hemorrhage","volume":"7","author":"Young","year":"2012","journal-title":"Curr Drug Saf"},{"key":"B89","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2337\/dc08-2064","article-title":"Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions","volume":"32","author":"Angiolillo","year":"2009","journal-title":"Diabetes Care"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1161\/01.STR.0000236841.16055.0f","article-title":"Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study","volume":"37","author":"van den Bergh","year":"2006","journal-title":"Stroke"},{"key":"B91","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF01403624","article-title":"Double-blind trial of aspirin in patient receiving tranexamic acid for subarachnoid hemorrhage","volume":"62","author":"Mendelow","year":"1982","journal-title":"Acta Neurochir"},{"key":"B92","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1212\/WNL.54.4.872","article-title":"Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage","volume":"54","author":"Hop","year":"2000","journal-title":"Neurology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3171\/jns.1985.63.5.0699","article-title":"Dipyridamole and postoperative ischemic deficits in aneurysmal subarachnoid hemorrhage","volume":"63","author":"Shaw","year":"1985","journal-title":"J Neurosurg"},{"key":"B94","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/01616412.1989.11739867","article-title":"Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study","volume":"11","author":"Suzuki","year":"1989","journal-title":"Neurol Res"},{"key":"B95","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/0090-3019(91)90228-2","article-title":"Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage","volume":"36","author":"Tokiyoshi","year":"1991","journal-title":"Surg Neurol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/09629359890910","article-title":"Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma","volume":"7","author":"van der Velden","year":"1998","journal-title":"Mediators Inflamm"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0140-6736(04)17188-2","article-title":"Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial","volume":"364","author":"Roberts","year":"2004","journal-title":"Lancet"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/S0140-6736(05)66552-X","article-title":"Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months","volume":"365","author":"Edwards","year":"2005","journal-title":"Lancet"},{"key":"B99","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/CCM.0b013e31829a70a5","article-title":"Bundle of measures for external cerebral ventricular drainage-associated ventriculitis","volume":"42","author":"Chatzi","year":"2014","journal-title":"Crit Care Med"},{"key":"B100","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12028-013-9930-2","article-title":"The impact of nonsteroidal anti-inflammatory drugs on inflammatory response after aneurysmal subarachnoid hemorrhage","volume":"20","author":"Muroi","year":"2013","journal-title":"Neurocrit Care"},{"key":"B101","first-page":"125","article-title":"Comparative efficacy of meloxicam and placebo in vasospasm of patients with subarachnoid hemorrhage","volume":"14","author":"Ghodsi","year":"2015","journal-title":"Iran J Pharm Res"},{"key":"B102","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S1474-4422(14)70084-5","article-title":"Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial","volume":"13","author":"Kirkpatrick","year":"2014","journal-title":"Lancet Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2018.00292\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:21:10Z","timestamp":1525252870000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2018.00292\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":102,"alternative-id":["10.3389\/fneur.2018.00292"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2018.00292","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,2]]},"article-number":"292"}}